Price
No data yet.
Social Signal Score
Analyst Ratings
Revenue
$433.59M+675.58%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Wang Huang
- Sector
- Technology
- Industry
- Consumer Electronics
- Employees
- 763
- Beta
- 1.81
- Country
- NL
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 0.12
Financials
Revenue
$433.59M+675.6%Net Income
$-77.33MEBITDA
$-83.99M-119779.3%Free Cash Flow
$0.00EPS (diluted)
$-78.56Shares Outstanding (diluted)
989.7K+5.7%Operating Expenses
$245.95MCash & Debt
$721.36MReturn of Capital
$0.00Revenue by Segment (annual)
$2.50BDividend per Share
$0.10Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.82B | $-280.92M | $-283.04 |
| 2024 | $1.33B | $-554.13M | $-34.08 |
| 2023 | $352.63M | $-31.13M | $-0.28 |
| 2022 | $615.72M | $-42.85M | $-0.40 |
| 2021 | $968.72M | $21.36M | $0.22 |
| 2020 | $931.73M | $33.13M | $0.34 |
| 2019 | $840.95M | $83.22M | $5.44 |
| 2018 | $578.52M | $53.97M | $1.31 |
| 2017 | $303.20M | $24.81M | $0.10 |
| 2016 | $234.24M | $3.60M | $-0.50 |
| 2015 | $142.56M | $-6.02M | $-3.04 |
Valuation
ZEPPhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70+40.00%Social Signal Score
Mentions (4)
- Newsseekingalpha.com·45d ago·Positive
Zepp Health Corporation (ZEPP) Q2 2026 Earnings Call Transcript Zepp Health Corporation (ZEPP) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·45d ago·Neutral
Zepp Health Q2 Earnings Call Highlights Zepp Health NYSE: ZEPP reported second-quarter 2026 revenue of $63.5 million, up 6.9% from a year earlier, as new product launches and a higher-priced product mix supported growth. Gross margin improved to 37.4% from 36.2% a year earlier despite higher memory and component costs, according to management.
View source ↗ - Newsprnewswire.com·45d ago·Neutral
Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results MILPITAS, Calif., Sept. 1, 2026 /PRNewswire/ -- Zepp Health Corporation (NYSE: ZEPP) ("Zepp", the "Company" or "we") today announced its unaudited financial results for the second quarter of 2026.
View source ↗ - Newsprnewswire.com·58d ago·Neutral
Zepp Health Corporation to Report Second Quarter 2026 Financial Results on September 1, 2026 Earnings Call Scheduled for 9:30 p.m. ET on September 1, 2026 MILPITAS, Calif.
View source ↗
Earnings
Wed, Nov 4(in 3 weeks)
Typical surprise -715.1% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Mar 26$-1.40 vs $0.23miss
Estimates and results for ZEPP via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ZEPP officers and directors.
- Bought
- —
- Sold
- $87k
0 trades
3 trades
- Yu Pengtaosold
- Yu Pengtaosold
- Deng Chengsold
22 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ZEPP.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.